AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
-8.84%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$12.6B
AUM Growth
-$1.88B
(-13%)
Cap. Flow
-$395M
Cap. Flow
% of AUM
-3.14%
Top 10 Holdings %
Top 10 Hldgs %
48.35%
Holding
1,050
New
210
Increased
412
Reduced
234
Closed
189
Top Buys
| 1 |
Eli Lilly
LLY
|
$47.3M |
| 2 |
SHLX
Shell Midstream Partners, L.P.
SHLX
|
$31.7M |
| 3 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
$13.5M |
| 4 |
Bath & Body Works
BBWI
|
$12M |
| 5 |
PPL Corp
PPL
|
$11.4M |
Top Sells
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
$153M |
| 2 |
Enterprise Products Partners
EPD
|
$105M |
| 3 |
PDCO
Patterson Companies, Inc.
PDCO
|
$48.8M |
| 4 |
MPLX
MPLX
|
$43.7M |
| 5 |
Plains All American Pipeline
PAA
|
$38M |
Sector Composition
| 1 | Energy | 56.01% |
| 2 | Healthcare | 3.42% |
| 3 | Financials | 3.23% |
| 4 | Materials | 2.9% |
| 5 | Consumer Discretionary | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Sibanye-Stillwater
SBSW
$6.08B
| $3.18M | 0.03% |
829,597
+582,450
| +236% | +$2.23M |
|
|
AKRX
177
DELISTED
Akorn, Inc.
AKRX
| $3.14M | 0.03% |
167,999
+29,406
| +21% | +$550K |
|
178
T Rowe Price
TROW
$23.8B
| $3.13M | 0.02% |
28,997
+10,149
| +54% | +$1.1M |
|
|
HZNP
179
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.12M | 0.02% |
219,807
+38,203
| +21% | +$542K |
|
180
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$13.7B
| $3.1M | 0.02% |
30,486
+78
| +0.3% | +$7.92K |
|
181
Boeing
BA
$174B
| $2.99M | 0.02% |
9,129
+2,995
| +49% | +$982K |
|
182
Plains GP Holdings
PAGP
$3.64B
| $2.99M | 0.02% |
137,596
-25,134
| -15% | -$547K |
|
|
GBT
183
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.98M | 0.02% |
61,706
+13,283
| +27% | +$641K |
|
184
NovaGold Resources
NG
$2.75B
| $2.96M | 0.02% |
684,630
+5,140
| +0.8% | +$22.3K |
|
185
Texas Instruments
TXN
$171B
| $2.94M | 0.02% |
28,340
+9,116
| +47% | +$947K |
|
|
PTLA
186
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.86M | 0.02% |
87,516
+15,210
| +21% | +$497K |
|
187
Ironwood Pharmaceuticals
IRWD
$188M
| $2.8M | 0.02% |
216,818
+37,682
| +21% | +$487K |
|
|
AERI
188
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.74M | 0.02% |
50,556
+9,883
| +24% | +$536K |
|
|
ENDP
189
DELISTED
Endo International plc
ENDP
| $2.72M | 0.02% |
457,917
+150,078
| +49% | +$891K |
|
190
Enanta Pharmaceuticals
ENTA
$189M
| $2.53M | 0.02% |
31,263
+10,169
| +48% | +$823K |
|
191
Cognizant
CTSH
$35.1B
| $2.51M | 0.02% |
31,155
+11,697
| +60% | +$942K |
|
192
Simon Property Group
SPG
$59.5B
| $2.5M | 0.02% |
16,199
-320
| -2% | -$49.4K |
|
193
FTAI Aviation
FTAI
$15.8B
| $2.47M | 0.02% |
181,622
+14,286
| +9% | +$195K |
|
194
Bank of America
BAC
$369B
| $2.47M | 0.02% |
82,291
+53,626
| +187% | +$1.61M |
|
195
Equinix
EQIX
$75.7B
| $2.47M | 0.02% |
5,896
+578
| +11% | +$242K |
|
|
AIMT
196
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $2.42M | 0.02% |
75,900
+19,538
| +35% | +$622K |
|
197
Prologis
PLD
$105B
| $2.39M | 0.02% |
37,958
+200
| +0.5% | +$12.6K |
|
198
Heron Therapeutics
HRTX
$201M
| $2.38M | 0.02% |
86,077
+25,679
| +43% | +$709K |
|
|
XLRN
199
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.37M | 0.02% |
60,670
+10,545
| +21% | +$412K |
|
|
MYOK
200
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.34M | 0.02% |
47,936
+8,332
| +21% | +$407K |
|